| CKPT Stock | | | USD 3.75 0.28 8.07% |
Checkpoint Therapeutics financial indicator trend analysis is way more than just evaluating Checkpoint Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Checkpoint Therapeutics is a good investment. Please check the relationship between Checkpoint Therapeutics Total Assets and its Common Stock Total Equity accounts. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Checkpoint Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in american community survey.
For more information on how to buy Checkpoint Stock please use our
How to Invest in Checkpoint Therapeutics guide.
Total Assets vs Common Stock Total Equity
Total Assets vs Common Stock Total Equity Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Checkpoint Therapeutics Total Assets account and
Common Stock Total Equity. At this time, the significance of the direction appears to have weak relationship.
The correlation between Checkpoint Therapeutics' Total Assets and Common Stock Total Equity is 0.31. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Common Stock Total Equity in the same time period over historical financial statements of Checkpoint Therapeutics, assuming nothing else is changed. The correlation between historical values of Checkpoint Therapeutics' Total Assets and Common Stock Total Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of Checkpoint Therapeutics are associated (or correlated) with its Common Stock Total Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock Total Equity has no effect on the direction of Total Assets i.e., Checkpoint Therapeutics' Total Assets and Common Stock Total Equity go up and down completely randomly.
Correlation Coefficient | 0.31 |
| Relationship Direction | Positive |
| Relationship Strength | Very Weak |
Total Assets
Total assets refers to the total amount of Checkpoint Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Checkpoint Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.
Common Stock Total Equity
The total value of common stock equity held by shareholders, representing their ownership interest in the company.
Most indicators from Checkpoint Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Checkpoint Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Checkpoint Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in american community survey.
For more information on how to buy Checkpoint Stock please use our
How to Invest in Checkpoint Therapeutics guide.
Sales General And Administrative To Revenue is likely to gain to 88.54 in 2024, whereas
Selling General Administrative is likely to drop slightly above 7.3
M in 2024.
Checkpoint Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Checkpoint Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Checkpoint Therapeutics fundamental ratios Accounts
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Checkpoint Stock Analysis
When running Checkpoint Therapeutics' price analysis, check to
measure Checkpoint Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Checkpoint Therapeutics is operating at the current time. Most of Checkpoint Therapeutics' value examination focuses on studying past and present price action to
predict the probability of Checkpoint Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Checkpoint Therapeutics' price. Additionally, you may evaluate how the addition of Checkpoint Therapeutics to your portfolios can decrease your overall portfolio volatility.